KIBRA is associated with accelerated cognitive decline and hippocampal atrophy in APOE ε4-positive cognitively normal adults with high Aβ-amyloid burden
Tenielle Porter(Edith Cowan University), Simon M. Laws(Edith Cowan University), David Groth(Curtin University), Giuseppe Verdile(Curtin University), Christopher C. Rowe(The University of Melbourne), Kimberly Begemann(University of Lübeck), Ashley I. Bush(Florey Institute of Neuroscience and Mental Health), Pierrick Bourgeat(CSIRO Health and Biosecurity), Colin L. Masters(Mental Health Research Institute), Victor L. Villemagne(The University of Melbourne), Stephanie R. Rainey‐Smith(Edith Cowan University), Lidija Milicic(Edith Cowan University), Paul Maruff(The University of Melbourne), Ralph N. Martins(Edith Cowan University), Samantha C. Burnham(Edith Cowan University), Vincent Doré(Australian e-Health Research Centre), David Ames(St George Hospital), Greg Savage(ARC Centre of Excellence in Cognition and its Disorders)
Cited by 37
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|7.1k
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
|New England Journal of Medicine|2012|3.8k
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
|Alzheimer s & Dementia|2016|1.9k
Alzheimer's disease
|Nature Reviews Disease Primers|2015|1.8k